Zyban goes generic
Executive Summary
Impax/Teva launch first generic version of GlaxoSmithKline's Zyban (bupropion 150 mg) after Andrx relinquishes 180-day marketing exclusivity. Impax' ANDA was approved March 27; under a July 2003 agreement, Andrx will share in the profits of the Impax/Teva product for six months. Andrx also gave up first-to-file rights on the compound for antidepressant use, allowing launch of Wellbutrin SR generics in March (1"The Pink Sheet" March 29, 2004, p. 27)...
You may also be interested in...
Wellbutrin SR Generics Multiply As Andrx Relinquishes Exclusivity
Andrx' agreement to give up its first-to-file ANDA exclusivity on a generic of GlaxoSmithKline's Wellbutrin SR 150 mg tablet means six companies will immediately share in the profits on sales of the generic antidepressant
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.